InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
G418 (Geneticin) | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
Zeocin® | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
Puromycin | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
pCpGfree-promoter | Identification of TMEM129, encoding a ubiquitin-protein ligase, as an effecto... | 2022 | Arthritis Res Ther. | Brumwell A. et al. | DOI: 10.1186/s13075-022-02882-y |
HEK-Blue™ hNOD1 | Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagemen... | 2022 | Front Pharmacol | Guzelj S. & Jakopin Z. | DOI: 10.3389/fphar.2022.920928 |
C12-iE-DAP | Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagemen... | 2022 | Front Pharmacol | Guzelj S. & Jakopin Z. | DOI: 10.3389/fphar.2022.920928 |
Zeocin® | Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagemen... | 2022 | Front Pharmacol | Guzelj S. & Jakopin Z. | DOI: 10.3389/fphar.2022.920928 |
Normocin® - Antimicrobial Reagent | Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagemen... | 2022 | Front Pharmacol | Guzelj S. & Jakopin Z. | DOI: 10.3389/fphar.2022.920928 |
Blasticidin | Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagemen... | 2022 | Front Pharmacol | Guzelj S. & Jakopin Z. | DOI: 10.3389/fphar.2022.920928 |
RAW-Blue™ Cells | Synthesis of bioactive (1→6)-β-glucose branched poly-amido-saccharides that s... | 2022 | Nat Commun. | Xiao R. et al. | DOI: 10.1038/s41467-022-32346-5 |
Rat IgG2a Control | Synthesis of bioactive (1→6)-β-glucose branched poly-amido-saccharides that s... | 2022 | Nat Commun. | Xiao R. et al. | DOI: 10.1038/s41467-022-32346-5 |
Anti-mouse Dectin-1 (CLEC7A) antibody | Synthesis of bioactive (1→6)-β-glucose branched poly-amido-saccharides that s... | 2022 | Nat Commun. | Xiao R. et al. | DOI: 10.1038/s41467-022-32346-5 |
Curdlan | Synthesis of bioactive (1→6)-β-glucose branched poly-amido-saccharides that s... | 2022 | Nat Commun. | Xiao R. et al. | DOI: 10.1038/s41467-022-32346-5 |
Pam3CSK4 | Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Respons... | 2022 | J Innate Immun. | Jansen A. et al. | DOI: 10.1159/000525572 |
Poly(I:C) HMW | Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Respons... | 2022 | J Innate Immun. | Jansen A. et al. | DOI: 10.1159/000525572 |
ODN M362 - TLR9 ligand | Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Respons... | 2022 | J Innate Immun. | Jansen A. et al. | DOI: 10.1159/000525572 |
R848 (Resiquimod) | Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Respons... | 2022 | J Innate Immun. | Jansen A. et al. | DOI: 10.1159/000525572 |
Blasticidin | CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cell... | 2022 | Viruses | Kedarinath K. et al. | DOI: 10.3390/v14081735 |
QUANTI-Blue™ | CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cell... | 2022 | Viruses | Kedarinath K. et al. | DOI: 10.3390/v14081735 |
Puromycin | CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cell... | 2022 | Viruses | Kedarinath K. et al. | DOI: 10.3390/v14081735 |